ABUS

#2566
Arbutus Biopharma Corporation Common Stock
4.35 USD
-0.46%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
4.35
4.35
년간 변동
2.94
5.10
일일 변동
-0.46%
월간 변동
+1.16%
6달 변화
+2.59%
년간 변동율
+32.62%
이전 종가
4.37
Open
4.35
Bid
Ask
Low
4.35
High
4.35
양
83
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

뉴스